Author

Pierre-Olivier Frappart

PARP INHIBITOR RESISTANCE INDUCES MASSIVE GENOME ALTERATIONS RESPONSIBLE OF THE ACQUISITION OF MULTIDRUG RESISTANCE IN DNA DAMAGE REPAIR-DEFICIENT PANCREATIC CANCER
PARP INHIBITOR RESISTANCE INDUCES MASSIVE GENOME ALTERATIONS RESPONSIBLE OF THE ACQUISITION OF MULTIDRUG RESISTANCE IN DNA DAMAGE REPAIR-DEFICIENT PANCREATIC CANCER

Pierre-Olivier Frappart  et al.

A NOVEL SYNERGISTIC THERAPY APPROACH TO TREAT DNA DAMAGE REPAIR DEFICIENT PANCREATIC CANCER
A NOVEL SYNERGISTIC THERAPY APPROACH TO TREAT DNA DAMAGE REPAIR DEFICIENT PANCREATIC CANCER

Pierre-Olivier Frappart  et al.

Item 1 - 2 / 2
1